Lack of Influence of the Apolipoprotein E Genotype on the Outcome of Selegiline Treatment in Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|16|1|31-34

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.16, Iss.1, 2003-05, pp. : 31-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Behavioural Pathology in Alzheimer’s Disease with Special Reference to Apolipoprotein E Genotype

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 4, 2002-11 ,pp. : 208-212

Karger

Access to resources Recommend Favorite

Apolipoprotein E Genotype in Sporadic Early- and Late-Onset Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 3, 1998-04 ,pp. : 121-125

Karger

Access to resources Recommend Favorite

Apolipoprotein E Genetic Variation and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 3, 1999-05 ,pp. : 199-209

Karger

Access to resources Recommend Favorite

Association Analysis of Apolipoprotein E Genotype and Risk of Depressive Symptoms in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 2-3, 2005-02 ,pp. : 154-157

Karger

Access to resources Recommend Favorite

Blood Levels of Alpha-1-Antichymotrypsin and Risk Factors for Alzheimer’s Disease: Effects of Gender and Apolipoprotein E Genotype

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 1, 2000-01 ,pp. : 25-28

Karger

Access to resources Recommend Favorite